News
Video
Author(s):
Leading oncologists discuss advanced treatment options for patients with progressing renal cell carcinoma (RCC), focusing on the promising results from LITESPARK-005 and treatment sequencing strategies.
Landmark Study Shows Elevated Cancer Risk For Women With Endometriosis
Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma
KIM-1 Demonstrates Potential Utility as a Biomarker With Worse DFS Outcomes in KIM-1–High RCC
Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting
Nivolumab/Tivozanib Fails to Improve PFS in Advanced RCC After Prior Immune Checkpoint Inhibition
Ibrutinib Plus Venetoclax Generates Durable CRs in TP53+ Mantle Cell Lymphoma
Dr Backhus on Surgical Eligibility in Borderline Resectable NSCLC
Dr Herbst on the Importance of Multidisciplinary Collaboration in NSCLC
Enhanced Clinical Education and Simplified Guidelines Needed to Address Germline Testing Gaps in Breast Cancer
Research Propels Additional Options into the Advanced HER2+ Breast Cancer Armamentarium